Nelonemdaz for Patients With Acute Ischemic Stroke Undergoing Endovascular Reperfusion Therapy: A Randomized Phase II Trial.
Journal Information
Full Title: Stroke
Abbreviation: Stroke
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Vascular Diseases
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Disclosures Drs Jin Soo Lee and Choi are advisory members to GNT pharma. The other authors report no conflicts."
"Sources of Funding This study was supported by GNT Pharma, Republic of Korea (no. Neu2000KWL-2015-P01). The sponsor was not involved in the study design, data interpretation, report preparation, and report submission. The decision to submit the article was made by all coauthors."
"Registration:: URL: https://clinicaltrials.gov; Unique identifier: NCT02831088."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025